Skip Navigation

A Phase II Open-Label Study of Sacituzumab Govitecan in Patients with Previously Treated Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma

Brief Summary

Type:
Gastrointestinal - Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT06178588

Study #:
STUDY00150700

Start Date:
Jan 07, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06178588

View Complete Trial Details & Eligibility at ClinicalTrials.gov